1. 130 REDUCED TOXICITY TREOSULFAN-BASED VS. REDUCED INTENSITY BUSULFAN-BASED CONDITIONING REGIMEN IN AML/MDS PATIENTS UNDERGOING ALLOGENEIC HAEMATOPOIETIC CELL TRANSPLANTATION: PRELIMINARY RESULTS OF A SINGLE CENTRE EXPERIENCE. Issue 1 (April 2015) Authors: Sakellari, I.; Mallouri, D.; Batsis, I.; Charalampidou, S.; Kaliou, M.; Afisidis, A.; Gavriilaki, E.; Constantinou, V.; Yannaki, E.; Kaloyannidis, P.; Apostolou, C.; Sotiropoulos, D.; Papalexandri, A.; Vadikoliou, C.; Smias, C.; Anagnostopoulos, A. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P1698: INCREASED COMPLEMENT ACTIVATION AND DECREASED ADAMTS13 ACTIVITY IN PATIENTS WITH PRE-ECLAMPSIA COMPARED TO HEALTHY PREGNANCIES. (23rd June 2022) Authors: Venou, T. M.; Varelas, C.; Gardikioti, A.; Vetsiou, E.; Klonizakis, P.; Daniilidis, A.; Christodoulou, I.; Koravou, E.-E.; Koutra, M.; Mavrikou, I.; Touloumenidou, T.; Papalexandri, A.; Sakellari, I.; Mandala, E.; Vlachaki, E.; Gavriilaki, E. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1579 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PB2183: RELAPSE PREDICTS POOR OUTCOMES IN FLT3-MUTATED ACUTE MYELOID LEUKEMIA POST ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION. (23rd June 2022) Authors: Gavriilaki, E.; Papalexandri, A.; Mallouri, D.; Batsis, I.; Vardi, A.; Bousiou, Z.; Demosthenous, C.; Panteliadou, A.; Spyridis, N.; Karavalakis, G.; Touloumenidou, T.; Masmanidou, M.; Pistiolas, G.; Mouladeniou, F.; Vadikoliou, C.; Lalayanni, C.; Yannaki, E.; Anagnostopoulos, A.; Sakellari, I. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 2053 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PB2226: THE ROLE OF COMPLEMENT IN THE IMMUNE RESPONSE OF SICKLE CELL DISEASE PATIENTS AFER COVID-19 VACCINATION. (23rd June 2022) Authors: Varelas, C.; Gavriilaki, E.; Sakellari, I.; Klonizakis, P.; Koravou, E.-E.; Christodoulou, I.; Mavrikou, I.; Kourelis, A.; Chatzopoulou, F.; Chatzidimitriou, D.; Touloumenidou, T.; Papalexandri, A.; Anagnostopoulos, A.; Vlachaki, E. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 2096 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Topic: AS01-Diagnosis/AS01c-Molecular aberrations (cytogenetic, genetic, gene expression): PATHOGENIC VARIANTS RELATED TO HEMATOLOGIC MALIGNANCIES CONTRIBUTE TO THE DIFFERENTIAL DIAGNOSIS OF CYTOPENIAS. (May 2023) Authors: Papalexandri, A.; Douka, V.; Iskas, M.; Papathanasiou, M.; Demosthenous, C.; Varelas, C.; Touloumenidou, T.; Sakellari, I. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Topic: AS08-Treatment/AS08b-Current treatment options – Lower risk MDS: LUSPATERCEPT IN LOWER-RISK MDS TRANSFUSION-DEPENDENT PATIENTS; A SINGLE-CENTRE EXPERIENCE. (May 2023) Authors: Papalexandri, A.; Iskas, M.; Paphianou, E.; Papathanasiou, M.; Marvaki, A.; Vadikoliou, C.; Athanasiadou, A.; Sakellari, I. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗